drugset / Trial / NCT00015288

Buprenorphine and Naloxone Combination Study - 10

NCT00015288

Double-blindTreatment

Summary

The purpose of this study is to examine pharmacokinetics and dose proportionality of sublingual tablets containing varying doses of buprenorphine and naloxone.

Timeline

Start
1996-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified Other
Subject Naloxone Small molecule Other

Indications